US Stock MarketDetailed Quotes

Regeneron Pharmaceuticals (REGN)

Watchlist
  • 834.040
  • +7.400+0.90%
Close Aug 21 16:00 ET
  • 834.040
  • 0.0000.00%
Post 20:01 ET
85.87BMarket Cap20.64P/E (TTM)

Regeneron Pharmaceuticals (REGN) Income Statement

Quarterly·All
YOY yoy
Hide blank lines yoy
Currency: USD
2026/Q2
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
2023/Q1
2022/Q4
2022/Q3
2022/Q2
2022/Q1
2021/Q4
2021/Q3
Total Revenue as Reported
+16.73%4.29B
+19.04%3.61B
+2.51%3.88B
+0.90%3.75B
+3.62%3.68B
-3.70%3.03B
+10.33%3.79B
+10.65%3.72B
+12.32%3.55B
-0.54%3.15B
+0.58%3.43B
+14.53%3.36B
+10.53%3.16B
+6.64%3.16B
-31.05%3.41B
-14.96%2.94B
-44.40%2.86B
+17.26%2.97B
+104.37%4.95B
+50.51%3.45B
Total Operating Revenue
+16.73%4.29B
+19.04%3.61B
+2.51%3.88B
+0.90%3.75B
+3.62%3.68B
-3.70%3.03B
+10.33%3.79B
+10.65%3.72B
+12.32%3.55B
-0.54%3.15B
+0.58%3.43B
+14.53%3.36B
+10.53%3.16B
+6.64%3.16B
-31.05%3.41B
-14.96%2.94B
-44.40%2.86B
+17.26%2.97B
+104.37%4.95B
+50.51%3.45B
Cost of Revenue
+8.73%576.50M
+44.17%669.40M
+3.40%584.60M
+6.21%521.60M
+10.41%530.20M
+7.03%464.30M
+9.36%565.40M
+12.53%491.10M
+18.60%480.20M
-5.18%433.80M
-4.37%517.00M
+37.32%436.40M
+36.28%404.90M
+12.99%457.50M
-44.98%540.60M
-29.88%317.80M
-57.17%297.10M
+31.46%404.90M
+178.28%982.60M
+65.40%453.20M
Gross Profit
+18.08%3.71B
+14.49%2.94B
+2.35%3.30B
+0.10%3.23B
+2.56%3.15B
-5.41%2.56B
+10.51%3.22B
+10.36%3.23B
+11.39%3.07B
+0.24%2.71B
+1.51%2.92B
+11.76%2.93B
+7.54%2.75B
+5.64%2.70B
-27.60%2.87B
-12.71%2.62B
-42.40%2.56B
+15.29%2.56B
+91.76%3.97B
+48.50%3.00B
Operating Expense
+11.57%2.29B
+11.77%2.19B
+8.17%2.40B
+6.46%2.12B
+4.18%2.06B
+0.39%1.96B
+15.95%2.22B
+16.24%1.99B
+13.63%1.97B
+14.74%1.95B
+12.81%1.91B
+22.99%1.72B
+38.58%1.74B
+33.62%1.70B
+32.43%1.70B
+21.03%1.39B
+14.18%1.25B
+14.95%1.27B
+41.94%1.28B
+19.19%1.15B
Selling and Admin Expenses
+4.40%662.10M
+2.32%647.70M
-2.17%775.00M
-7.92%657.80M
-16.42%634.20M
-8.13%633.00M
+7.39%792.20M
+11.54%714.40M
+16.38%758.80M
+14.62%689.00M
+11.69%737.70M
+21.05%640.50M
+36.89%652.00M
+33.58%601.10M
+18.03%660.50M
+18.90%529.10M
+14.85%476.30M
+10.95%450.00M
+84.38%559.60M
+36.13%445.00M
Research & Development
+14.76%1.63B
+16.28%1.54B
+15.15%1.63B
+16.00%1.48B
+18.48%1.42B
+6.33%1.33B
+19.95%1.41B
+18.25%1.27B
+10.57%1.20B
+13.37%1.25B
+12.86%1.18B
+18.00%1.08B
+36.64%1.09B
+30.50%1.10B
+41.42%1.04B
+36.96%911.30M
+11.22%794.30M
+13.58%843.80M
-0.93%737.60M
-2.80%665.40M
Other Operating Expenses
----
----
-100.00%0.00
-225.00%-10.00M
----
----
+3200.00%15.50M
+1700.00%8.00M
+2533.33%14.60M
+3160.00%15.30M
+92.42%-500.00K
+98.91%-500.00K
+96.55%-600.00K
+97.52%-500.00K
+58.23%-6.60M
-208.81%-45.70M
+44.41%-17.40M
+50.12%-20.20M
+89.12%-15.80M
+194.17%42.00M
Operating Profit
+30.38%1.42B
+23.31%744.80M
-10.50%898.60M
-10.18%1.11B
-0.37%1.09B
-20.37%604.00M
+0.11%1.00B
+2.04%1.24B
+7.58%1.09B
-24.36%758.50M
-14.78%1.00B
-1.04%1.21B
-22.22%1.02B
-22.06%1.00B
-56.22%1.18B
-33.75%1.22B
-60.96%1.31B
+15.63%1.29B
+130.31%2.69B
+75.41%1.85B
Net Non-Operating Interest Income (Expense)
+0.64%172.30M
+3.52%170.60M
+4.92%181.10M
-10.25%155.80M
+4.01%171.20M
+13.34%164.80M
+32.36%172.60M
+49.78%173.60M
+65.59%164.60M
+88.34%145.40M
+145.57%130.40M
+319.93%115.90M
+558.28%99.40M
+1475.51%77.20M
+67.51%53.10M
+294.37%27.60M
+204.86%15.10M
+133.56%4.90M
+314.19%31.70M
+46.01%-14.20M
Non-Operating Interest Income
+4.86%183.30M
+5.76%183.50M
+5.57%193.30M
-6.56%175.10M
-2.56%174.80M
+7.43%173.50M
+23.13%183.10M
+40.16%187.40M
+51.65%179.40M
+69.64%161.50M
+110.92%148.70M
+211.66%133.70M
+319.50%118.30M
+414.59%95.20M
--70.50M
--42.90M
--28.20M
--18.50M
----
----
Non-Operating Interest Expense
+205.56%11.00M
+48.28%12.90M
+16.19%12.20M
+39.86%19.30M
-75.68%3.60M
-45.96%8.70M
-42.62%10.50M
-22.47%13.80M
-21.69%14.80M
-10.56%16.10M
+5.17%18.30M
+16.34%17.80M
+44.27%18.90M
+32.35%18.00M
+23.40%17.40M
+7.75%15.30M
-9.03%13.10M
-6.85%13.60M
-4.73%14.10M
-46.01%14.20M
Other Income (Expense)
-125.19%-65.00M
-161.82%-84.20M
+83.52%-36.00M
+494.50%497.60M
-30.27%258.00M
+167.03%136.20M
-1627.97%-218.50M
+138.73%83.70M
+1221.21%370.00M
+8.47%-203.20M
-84.92%14.30M
-183.60%-216.10M
+90.80%-33.00M
+3.65%-222.00M
+143.89%94.80M
+1676.22%258.50M
-185.43%-358.80M
-248.74%-230.40M
-398.34%-216.00M
+42.46%-16.40M
Gain on Sale of Security
-75.24%61.90M
-82.13%25.00M
+89.90%-21.50M
+328.88%577.70M
-36.31%250.00M
+171.30%139.90M
-821.69%-212.90M
+234.30%134.70M
+1370.23%392.50M
-19.13%-196.20M
-77.48%29.50M
-139.44%-100.30M
+81.12%-30.90M
+22.02%-164.70M
--131.00M
--254.30M
---163.70M
---211.20M
----
----
Special Income (Charges)
-1170.00%-127.00M
-728.46%-101.90M
-35.51%-18.70M
-47.86%-83.10M
+58.16%-10.00M
-73.24%-12.30M
+54.00%-13.80M
+43.80%-56.20M
---23.90M
+87.34%-7.10M
+0.00%-30.00M
---100.00M
+100.00%0.00
-99.64%-56.10M
+37.50%-30.00M
--0.00
---197.00M
---28.10M
---48.00M
--0.00
-Less:Other Special Charges
+1170.00%127.00M
+728.46%101.90M
+35.51%18.70M
+47.86%83.10M
-58.16%10.00M
+73.24%12.30M
-54.00%13.80M
-43.80%56.20M
--23.90M
-87.34%7.10M
+0.00%30.00M
--100.00M
----
+99.64%56.10M
--30.00M
----
--197.00M
--28.10M
----
----
Other Non-Operating Income (Expenses)
-99.44%100.00K
-184.88%-7.30M
-48.78%4.20M
-42.31%3.00M
+1185.71%18.00M
+8500.00%8.60M
-44.59%8.20M
+132.91%5.20M
+166.67%1.40M
+108.33%100.00K
+338.71%14.80M
-476.19%-15.80M
-210.53%-2.10M
-113.48%-1.20M
+98.88%-6.20M
+125.61%4.20M
-99.55%1.90M
-94.25%8.90M
-865.88%-554.50M
+42.46%-16.40M
Pretax Profit
+0.60%1.53B
-8.15%831.20M
+8.93%1.04B
+18.10%1.76B
-6.72%1.52B
+29.16%905.00M
-16.51%958.10M
+34.41%1.49B
+50.35%1.63B
-18.33%700.70M
-13.37%1.15B
-26.43%1.11B
+12.43%1.08B
-19.14%858.00M
-47.08%1.32B
-16.89%1.51B
-74.33%963.20M
-15.32%1.06B
+104.43%2.50B
+81.97%1.82B
Tax
+81.67%230.90M
+8.00%104.00M
+392.82%199.10M
+99.02%303.30M
-35.09%127.10M
+552.11%96.30M
+436.67%40.40M
+47.96%152.40M
+71.00%195.80M
-152.99%-21.30M
-109.40%-12.00M
-46.93%103.00M
+3.06%114.50M
-54.11%40.20M
-53.50%127.60M
+5.26%194.10M
-83.01%111.10M
-36.43%87.60M
+263.93%274.40M
+18.05%184.40M
Net Profit
-6.81%1.30B
-10.08%727.20M
-7.97%844.60M
+8.91%1.46B
-2.84%1.39B
+12.01%808.70M
-20.86%917.70M
+33.02%1.34B
+47.90%1.43B
-11.71%722.00M
-3.13%1.16B
-23.40%1.01B
+13.65%968.40M
-15.99%817.80M
-46.29%1.20B
-19.39%1.32B
-72.50%852.10M
-12.71%973.50M
+93.96%2.23B
+93.82%1.63B
Profit from Continuing Operations
-6.81%1.30B
-10.08%727.20M
-7.97%844.60M
+8.91%1.46B
-2.84%1.39B
+12.01%808.70M
-20.86%917.70M
+33.02%1.34B
+47.90%1.43B
-11.71%722.00M
-3.13%1.16B
-23.40%1.01B
+13.65%968.40M
-15.99%817.80M
-46.29%1.20B
-19.39%1.32B
-72.50%852.10M
-12.71%973.50M
+93.96%2.23B
+93.82%1.63B
Net Income to Parent Company
-6.81%1.30B
-10.08%727.20M
-7.97%844.60M
+8.91%1.46B
-2.84%1.39B
+12.01%808.70M
-20.86%917.70M
+33.02%1.34B
+47.90%1.43B
-11.71%722.00M
-3.13%1.16B
-23.40%1.01B
+13.65%968.40M
-15.99%817.80M
-46.29%1.20B
-19.39%1.32B
-72.50%852.10M
-12.71%973.50M
+93.96%2.23B
+93.82%1.63B
Net Income to Common Stockholders
-6.81%1.30B
-10.08%727.20M
-7.97%844.60M
+8.91%1.46B
-2.84%1.39B
+12.01%808.70M
-20.86%917.70M
+33.02%1.34B
+47.90%1.43B
-11.71%722.00M
-3.13%1.16B
-23.40%1.01B
+13.65%968.40M
-15.99%817.80M
-46.29%1.20B
-19.39%1.32B
-72.50%852.10M
-12.71%973.50M
+93.96%2.23B
+93.82%1.63B
Basic EPS
-4.68%12.62
-7.78%6.99
-3.75%8.21
+13.63%14.09
-0.08%13.24
+13.13%7.58
-21.60%8.53
+30.80%12.40
+46.41%13.25
-12.30%6.70
-2.77%10.88
-22.99%9.48
+14.56%9.05
-16.23%7.64
-46.69%11.19
-19.91%12.31
-73.23%7.90
-13.80%9.12
+92.57%20.99
+92.61%15.37
Diluted EPS
-4.53%12.23
-7.15%6.75
-2.48%7.86
+18.02%13.62
+3.22%12.81
+15.95%7.27
-20.90%8.06
+29.81%11.54
+46.00%12.41
-12.55%6.27
-2.95%10.19
-23.76%8.89
+13.79%8.50
-16.72%7.17
-46.67%10.50
-18.63%11.66
-73.29%7.47
-14.67%8.61
+92.29%19.69
+93.91%14.33
Dividend Per Share
+6.82%0.94
+6.82%0.94
--0.88
--0.88
--0.88
--0.88
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Deadline
Jun 30, 2026
Mar 31, 2026
Dec 31, 2025
Sep 30, 2025
Jun 30, 2025
Mar 31, 2025
Dec 31, 2024
Sep 30, 2024
Jun 30, 2024
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Accounting Standard
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
2026/Q22026/Q12025/Q42025/Q32025/Q22025/Q12024/Q42024/Q32024/Q22024/Q12023/Q42023/Q32023/Q22023/Q12022/Q42022/Q32022/Q22022/Q12021/Q42021/Q3
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Ahead of the market open, US Treasury Secretary Bessent indicated that the United States and Iran are poised to reach an agreement the follo Show More